Abeona Therapeutics Inc.
ABEO· Nasdaq
Released Nov 14, 2012, after the close
10-Q filed Nov 14, 2012, 45 days after period end · 0000318306-12-000057
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $871.00K | $1.04M | $127.00K |
| Net Income | -$14.87M | $350.00K | -$12.72M |
| EPS Diluted | -$0.63 | $0.00 | -$0.83 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Abeona Therapeutics Inc. · CIK 318306 · Engraved from SEC EDGAR